Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
49.94
+0.68 (1.38%)
Aug 4, 2026, 4:00 PM EDT - Market closed
Sionna Therapeutics Market Cap
Sionna Therapeutics has a market cap or net worth of $2.25 billion as of August 4, 2026. Its market cap has increased by 202.24% in one year.
Market Cap
2.25B
Enterprise Value
1.97B
1-Year Change
202.24%
Ranking
Category
Stock Price
$49.94
ChartMarket Cap Chart
Since the IPO on February 7, 2025, Sionna Therapeutics's market cap has increased from $733.61M to $2.25B, an increase of 207.36%. That is a compound annual growth rate of 112.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 2.25B | 22.81% |
| Dec 31, 2025 | 1.84B | 150.27% |
| Feb 7, 2025 | 733.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Precigen | 2.37B |
| Vericel | 2.36B |
| Kailera Therapeutics | 2.32B |
| Pharvaris | 2.32B |
| Mineralys Therapeutics | 2.30B |
| SELLAS Life Sciences Group | 2.27B |
| Hemab Therapeutics Holdings | 2.26B |
| Nuvation Bio | 2.25B |